LFHClass II
U.V. Spectrometry, Tricyclic Antidepressant Drugs
21 CFR 862.3910 / Clinical Toxicology
LFH is the FDA product code for U.V. Spectrometry, Tricyclic Antidepressant Drugs, a class II device type, regulated under 21 CFR 862.3910. As of , FDA records hold 6 510(k) clearances under this code, the most recent dated , and 3 recalls.
Classification record
- Product code
- LFH
- Device name
- U.V. Spectrometry, Tricyclic Antidepressant Drugs
- Regulation
- 21 CFR 862.3910
- Device class
- Class II
- Review panel
- Clinical Toxicology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 6
- Ingested recalls
- 3
Clearances, product code LFH
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1995 | 1 |
| 1996 | 1 |
| 1998 | 2 |
| 2022 | 1 |
| 2023 | 1 |
Applicants with the most clearances
Product code LFH| Applicant | Clearances |
|---|---|
| Diagnostic Reagents, Inc. | 2 |
| Microgenics Corporation | 2 |
| Abbott Medical | 1 |
| Princeton BioMeditech Corp. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
